Skip to content
← Back to this collection

PUBLICATIONS · 16098243

Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Clin Lung Cancer
Publication date
2005 Jul
First author
Jänne PA

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Jänne PA
      type
      Author
    2. name
      Wozniak AJ
      type
      Author
    3. name
      Belani CP
      type
      Author
    4. name
      Keohan ML
      type
      Author
    5. name
      Ross HJ
      type
      Author
    6. name
      Polikoff JA
      type
      Author
    7. name
      Mintzer DM
      type
      Author
    8. name
      Taylor L
      type
      Author
    9. name
      Ashland J
      type
      Author
    10. name
      Ye Z
      type
      Author
    11. name
      Monberg MJ
      type
      Author
    12. name
      Obasaju CK
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Jänne PA
      type
      Author
    2. name
      Wozniak AJ
      type
      Author
    3. name
      Belani CP
      type
      Author
    4. name
      Keohan ML
      type
      Author
    5. name
      Ross HJ
      type
      Author
    6. name
      Polikoff JA
      type
      Author
    7. name
      Mintzer DM
      type
      Author
    8. name
      Taylor L
      type
      Author
    9. name
      Ashland J
      type
      Author
    10. name
      Ye Z
      type
      Author
    11. name
      Monberg MJ
      type
      Author
    12. name
      Obasaju CK
      type
      Author
    bibliography ids
    1. nci-bib-17cab1891160d740287fbb76
    book metadata
    content sha256
    3bdcba9966281c1a1fa16e2d4224a209e995bbe19d998742e266da7ed1b17b76
    document type
    citation
    dois
    1. 10.3816/CLC.2005.n.020
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:16098243
    immutable id
    pubmed:16098243@3bdcba9966281c1a1fa16e2d4224a209e995bbe19d998742e266da7ed1b17b76
    journal
    abbreviation
    Clin Lung Cancer
    issn electronic
    Source null
    issn print
    1525-7304
    issue
    1
    name
    Clinical lung cancer
    nlm unique id
    100893225
    pages
    40-6
    volume
    7
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      16098243
      provenance
      batch id
      acd1a19ec1fd03e5b423
      provider
      NCBI PubMed ESummary
      record sha256
      d9807d10d7ba4424f630ec3bb08ec007c8cba780607c46a930626254c7728c93
      response sha256
      06f2789b1faf1384eea463ec33b6ace6458084d0e39588df6f3b23cecac27647
      retrieved at
      2026-09-09T23:46:01.895425+00:00
      publication date
      display
      2005 Jul
      precision
      month
      year
      2005
      publication types
      1. Clinical Trial
      2. Journal Article
      3. Research Support, Non-U.S. Gov't
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/16098243/
      title
      Open-label study of pemetrexed alone or in combination with cisplatin for the treatment of patients with peritoneal mesothelioma: outcomes of an expanded access program.

      Preserved source evidence · Not medical advice